Cytomegalovirus (CMV) is a widespread pathogen that is
Cytomegalovirus infection in humans
Human cytomegalovirus (HCMV) is a ␤-herpesvirus that infects more than 70% of the world population regardless of geographical location or gender. 1, 2 Following primary infection, HCMV establishes long-term latency with intermittent reactivation. 1, 3 Usually asymptomatic in immunocompetent individuals, HCMV infections may result in severe or even fatal disease in immunocompromised patients. [4] [5] [6] In addition, HCMV is the leading cause of congenital viral infection in humans, with an incidence of 0.2-2.2% amongst live births, of which at least 10% will present with birth defects such as hearing loss or mental retardation. 7, 8 Interestingly, in the general population the clinical outcome of HCMV infection is non-random as polymorphisms in genes of pro-inflammatory cytokines (TNF-␣, IL-1RA) are in association with seropositivity. 9 HCMV is also responsible for a substantial fraction of the morbidity and mortality that occurs following organ transplantation. [10] [11] [12] [13] [14] In the transplant setting, symptomatic HCMV infection encompasses a range of clinical illnesses including interstitial pneumonia in 50-90% of bone marrow recipients and organ-specific disease in 20-40% of solid organ transplant recipients. [15] [16] [17] [18] [19] In transplant recipients susceptibility has been associated with specific genotypes, in particular with alleles of the human leucocyte antigen (HLA) locus, also indicating a genetic component of susceptibility. 20 HCMV diseases, including retinitis, colitis, and encephalitis, occur in persons with AIDS and have been associated with decreased survival after diagnosis of HIV infection. [21] [22] [23] Additionally, the impact of HCMV infection in the general population may have been underrated since clinical and experimental evidence is accumulating that there may be a link between HCMV infection and vascular disease. [24] [25] [26] For example, HCMV seropositivity is a strong risk factor associated with restenosis following coronary atherectomy 27, 28 and transplant-associated atherosclerosis in heart transplant patients, 29, 30 whereas in animal models, murine CMV (MCMV) infection accelerates formation of atheromatous lesions in apoE −/− mice. 31, 32 Moreover, a related herpesvirus known as Marek's disease virus (MDV) was found to cause the formation of atherosclerotic lesions in the aortas of chickens and led to accumulation of cholesterol in the aortic wall of MDV-infected chickens. 33 There is currently no vaccine available against HCMV and benefits of treatment with available drugs-foscarnet, gancyclovir and cidofovir-are undermined by toxicity and emergence of drug-resistant strains [34] [35] [36] [37] indicating the need for additional therapeutic approaches. The serious medical problems associated with HCMV infection have thus stimulated research aimed at understanding the complex interplay of viral and host functions that lead to pathogenesis. In this respect, understanding, at the molecular level, the early immune responses against HCMV infection could provide a rationale for developing alternative therapeutic strategies that either stimulate or exploit host resistance mechanisms.
Natural killer (NK) cells and innate immunity against HCMV
Innate immunity is the first arm of defense against infection, providing a rapid (hours to days) and, most of the time, efficacious mechanism to eliminate pathogens. In particular, NK cells represent a component of the innate system that seem to be particularly important during infection with herpesviruses, including CMV. 38 NK cells are so named because of their propensity to kill, without prior sensitization, certain neoplastic and virus-infected cells as well as normal allogenic bone marrow-derived cells. 39 The crucial role of NK cells in controlling primary CMV infection and reactivation, in humans and in experimental infections in mice, has been recognized for more than 20 years. 40 Data from naturally acquired infections indicate that low NK cell cytotoxic activity is linked with increased sensitivity to severe, disseminating, human herpesgroup viral infections, including herpes simplex virus (HSV), Epstein-Barr virus (EBV), and HCMV. 38 In graft recipients, low NK cell activity is associated with HCMV reactivation and poor prognosis. 41, 42 The most direct evidence supporting a role for NK cells in defense against herpesviruses comes from a patient identified with a complete lack of NK cells as well as no spontaneous or IL-2-inducible NK cell cytotoxic function. 43 Initially, this young patient presented with an overwhelming Herpes Zoster infection and developed, during the next 5 years, primary life-threatening HCMV infection and a severe HSV infection despite normal antibody and memory T cell functions. In addition, the identification of the molecular defect in X-linked lymphoproliferative (XLP) syndrome provided genetic evidence for the involvement of NK cells in viral defense. XLP patients are highly susceptible to EBV infection which results in fatal infectious mononucleosis, agammaglobulinemia, or B-cell lymphoma as a result of aberrant T cell and NK cell responses. 44 The XLP phenotype is the result of a mutation in the gene encoding the SH2 domain protein-1A (SH2D1A), 45 also known as SLAM-associated protein (SAP). 46 SAP is exclusively expressed on T cells and NK cells where it controls activation pathways initiated by the signaling lymphocyte activation molecule (SLAM), expressed in T cells, 46 or 2B4, an NK cell-specific protein implicated in the response to EBV. [47] [48] [49] Together these data confirm the importance of NK cells during infection by CMV and other herpes viruses.
Mouse models of CMV infection
Experimental models of infection of mice with MCMV have provided an excellent tool for the in vivo dissection
Genes and Immunity of the individual components of the host response that are important in mediating resistance to MCMV infection. Infection of mice with MCMV mimics virus-induced disease in humans in terms of presenting a large spectrum of clinical manifestations. For example, high viral titres in target organs are associated with pneumonitis, 50 hepatitis 51 and retinitis. 52, 53 Moreover high viral titres in the spleen or liver may lead to fatal infection. 54 There are also models of congenital viral infection by MCMV. 55, 56 In addition, different strains of inbred mice exhibit striking differences in their level of susceptibility to MCMV infection, as measured by organ-specific viral replication in the first days after infection, disease severity and survival. 57, 58 These distinct patterns of susceptibility reveal genetic differences between strains that make the mouse an excellent model to examine the heterogeneous responses seen in humans and facilitate a genetic approach to the mapping of susceptibility traits. Furthermore, identification of the genetic determinants of MCMV-susceptibility in the mouse may aid in identification of key host response mechanisms and molecules required for control of viral infection in humans.
Mouse studies have provided evidence supporting an important role for NK cells in combating viral disease, particularly during the very early stages of infection. 59 Increased sensitivity to infection with MCMV 60 and HSV 61 was observed after in vivo depletion of NK cells with the monoclonal antibodies PK136 or anti-asialoGM1, which recognize surface antigens preferentially expressed on NK cells. Moreover, the identification of spontaneous mutations as well as the accessibility of the mouse genome to targeted mutagenesis helped to define key molecules participating in host defense against herpesviruses. As shown in Table 1 , the vast majority of natural and induced mutations determining susceptibility to herpesvirus affect either the activation or function of NK cells and/or T cells. For example, the absence of chemokines normally expressed early during infection such as MIP1␣ (a mediator of inflammation) or of cytokines of the innate immune response such as IL-12 and IL-18 that stimulate IFN-␥ production by NK cells as well as T cells, result in high MCMV susceptibility. 66, 67, 71 In addition, beige mice, which have a genetic disorder homologous to Chediak-Higashi syndrome (CHS) of man, exhibit defective NK activity despite the presence of normal numbers of NK cells and are highly susceptible to infection with MCMV. 79 The beige mutation occurs within a gene encoding a protein called LYST, a regulatory protein required for appropriate vesicle trafficking in granule-containing cells including NK cells. 80 Similarly, mice carrying targeted mutations within genes involved in the cytolytic function of NK cells including those encoding perforin 64, 69, 73 and granzyme A/B 64 also demonstrate high susceptibility to MCMV infection. Together these results indicate that both immunoregulatory and cytolytic function of T lymphocytes and NK cells are crucial for the control of MCMV infection.
The distinct phenotypes of MCMV susceptibility exhibited by different inbred strains have stimulated investigation of the genetic components of resistance. Resistance of adult mice to organ-specific, viral replication early during infection or to acute lethal infection with MCMV is controlled, in part, by genes of the H2 complex that encode classical MHC class I molecules. Studies in H2 congenic mouse strains demonstrated that animals pos- 
The Cmv1 locus
Despite the well-established role of the H2 complex in MCMV infection, a number of genetic studies have also demonstrated that non-H2 factors contribute to the pattern of resistance and susceptibility to MCMV, particularly during the early stages of infection and in distinct target organs. Specifically, enumeration of MCMV viral titers in the spleens and livers of different inbred mouse strains identified highly resistant and highly susceptible strains in terms of target organ replication. 57 These non-H2 genes have been shown to primarily affect NK cell function, 60 once again supporting an important role of this cell population in the control of MCMV infection. Genetic studies using these MCMV resistant and susceptible strains as parental strains to generate segregating F 2 and backcross populations identified a single locus, Cmv1, which controls viral replication in an autosomal dominant fashion. 85 Common inbred strains present two allelic forms for Cmv1: a dominant resistant allele, Cmv1 r , expressed in mice of the C57BL/6J background and a recessive susceptible allele, Cmv1 s , expressed in BALB/cJ, A/J and DBA/2J strains. Phenotypically, resistant mice display splenic viral titers 10 3 to 10 4 -fold lower than those found in susceptible mice at day 3 post-infection with a sub-lethal dose of virus.
Cmv1 also contributes to MCMV replication in the bone marrow and thymus and plays a role in determining the outcome of infection after injection with a lethal dose of virus. 86 Studies in radiation chimeras following bone marrow transplantation together with in vivo depletion experiments indicated that the effect of Cmv1 is mediated primarily by NK cells. 60 Mechanisms by which NK cells bearing the Cmv1 r allele are able to control early MCMV replication are unknown, however, studies in mice bearing targeted disruptions at specific genes together with antibody depletion experiments indicate that the action of Cmv1 is comprised of a perforin-dependent and IFN-␥-independent function. 87, 88 The chromosomal location of Cmv1 and identification of nearby loci was determined by assessment of the inheritance pattern from two sets of recombinant inbred (RI) parent strains, CXB and BXD. 85 The inheritance pattern of Cmv1 from the RI strains was identical to that of a set of markers known to reside on a region of chromosome 6 called the NK complex (NKC). 85 The NKC contains genes and gene families preferentially expressed in NK cells and since host NK cells are responsible for the control of early MCMV viral replication, the NKC region was considered to be fertile grounds for uncovering a potential candidate for Cmv1.
In the mouse, the NKC is a 2 Mb genomic region that contains genes encoding a variety of surface receptors expressed on NK cells and some T cell populations ( Figure 1a) . 89 Of particular interest, Ly49 receptors are encoded by a family of as many as 14 homologous genes that are expressed in overlapping subsets of NK cells and bind classical MHC class I molecules. CD94 is encoded by a single gene whereas NKG2 is comprised of a multigene family (NKG2A, C, D and E in the mouse) forming heterodimers that bind non-classical MHC class I molecule Qa-1 (HLA-E in human). 94 The NKC also contains the Nkrp gene family (Ͼ3 members, including Nk1.1) 95 and other single genes such as Shp1 (SH2-containing protein tyrosine phosphatase) that are also involved in NK- (a) Genetic organization of the NKC on human chromosome 12p13 and the syntenic region on mouse chromosome 6. Genes of the NKC code for C-type lectin receptors. Note the expansion of the genomic region in the vicinity of the LY49L pseudogene on the mouse chromosome domain harboring the Ly49 gene family. MAGOH (Mago nashi homologue), 90 CSDA (cold shock domain protein A), 91 T2R (taste receptor) 92 and PRP (proline-rich protein) 93 are tightly linked to the NKC although functionally unrelated. (b) Genetic organization of the LRC on human chromosome 19q13 and the syntenic region on mouse chromosome 7. Genes of the LRC encode for receptors of the immunoglobulin superfamily. Note the absence of the KIR domain on mouse chromosome 7.
cell activity. 96 The NKC is conserved between mouse chromosome 6, rat chromosome 4 and human chromosome 12p. In contrast to the rodent species, the Ly49 gene cluster is absent in humans (a single copy of the Ly49L gene has been identified in the human genome, however, no functional mRNA has yet been detected) (Figure 1a) . 97 In humans, the family of killer cell immunoglobulinlike receptors (KIR) are considered the functional homologues of mouse Ly49 proteins. 98 KIR receptors are specific for various MHC class I molecules, they are expressed in overlapping subsets of NK cells, and include inhibitory or activating members that signal through the same intracellular pathways as Ly49 molecules. KIR genes are localized to chromosome 19q13 in a region known as the leukocyte receptor cluster (LRC) (Figure 1b) . 98, 99 This region also encodes other members of the immunoglobulin superfamily such as the immunoglobulin-like transcrips (ILTs) and the leukocyte-associated inhibitory receptor (LAIRs) that are expressed on an extended range of cell types, as well as NKp46, an activating NK receptor. Whereas Nkp46 and the gene cluster of paired-immunoglobulin like receptor family (Pir), likely orthologous of ILTs, are localized to a syntenic region on mouse chromosome 7, KIRs are completely absent from rodents ( Figure 1b) . 100, 101 A remarkable feature of the NKC is the presence of Genes and Immunity numerous loci associated with immune function and infection susceptibility (Figure 1a) . In addition to containing the Cmv1 gene which confers resistance to MCMV, the NKC region has been linked to other phenotypes dependent upon NK cell-mediated immunity such as Chok, a mouse locus controlling tumor killing by NK cells. 102 Moreover, loci contributing to susceptibility to cutaneous leishmaniasis, 103 insulin-dependent diabetes mellitus 104 and ectromelia virus 105 in mice have been also localized to this chromosomal region. In rats, Nka, an autosomal dominant locus that controls NK cell lysis of allogeneic lymphocytes 106 and Oia2, a locus controlling susceptibility to oil-induced arthritis has been mapped to the rat NKC. 107 Not surprisingly, the KIR in human has been associated with loci controlling innate or autoimmune immunity such as tumor killing 108 and rheumatoid arthritis.
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Cloning of Cmv1
The identification of Cmv1 appeared as a central point to understanding not only the genetic control of host susceptibility to MCMV infection but also the relationship of Cmv1 to other loci mapped to the NKC considering coordinate function of genes of the NKC in NK cellmediated activities. Based upon the function and NK-specific expression, all members of the NKC were considered potential candidates for Cmv1. Therefore, an approach based on meiotic mapping and the definition of a minimal genetic interval for the localization of Cmv1 seemed the most rational approach to identify the locus. Fine genetic mapping helped to define a minimal genetic interval containing candidate genes for Cmv1 as well as to identify genes exterior to the interval that were unrelated to the susceptibility phenotype. In addition, cloning of the minimal genetic interval from large insert libraries provided a means to isolate all potential candidate genes. Lastly, the candidacy of individual genes was assessed by mutational analysis of the corresponding cDNAs obtained from Cmv1 r and Cmv1 s mouse strains. As the race to identify the gene within the NKC responsible for MCMV resistance/susceptibility ensued, several mapping panels were produced to help localize Cmv1. These included (BALB/cJ × C57BL/6J)F1 × BALB/cJ and (A/J × C57BL/6J)F1 × A/J 110 informative back-cross mice as well as 18 lines of recombinant congenic strains at the NKC 110 totaling more than 3500 meiosis. Segregation analysis of polymorphic markers, including microsatellite markers, gene sequences and anonymous probes, with respect to Cmv1 lead to the localization of Cmv1 to a 0.35-cM interval in two independent genetic maps. [110] [111] [112] The map generated by our group revealed gene order and intergene distances (in cM) in the vicinity of Cmv1 as: (Figure 2a) . A high-resolution physical map of the Cmv1 genetic interval based on long-range restriction mapping by PFGE and the assembly of a contig of YAC and BAC clones translated the genetic interval into 1.6 Mb of genomic DNA containing a minimum of 18 transcription units including the 14 Ly49 gene cluster (Figure 2b, c) . 112 These results excluded Nk1.1, Cd94 and Nkg2d, while retaining the Ly49 gene cluster as candidates for Cmv1. [110] [111] [112] Interestingly, a similar mapping approach being performed by a second group initially excluded Ly49 genes as potential candidates by placing Cmv1 distal to Ly49b gene, raising the possibility that one or more NKC genes could be involved in the resistance/susceptibility phenotype. 115 Sequence comparison between Cmv1 r and Cmv1 s strains indicated allelic differences for transcripts analyzed in the Cmv1 interval 116, 117 ( Figure 2b, Figure 3 ), precluding assessment of their candidacy based upon mutation analysis. In addition, the complex structural organization of the Ly49 gene family further complicated the analysis of the Cmv1 domain as many of the Ly49 genes have different copy numbers and genomic organization in inbred strains, making it difficult to distinguish allelic variants of the same or of distinct Ly49 gene copies. 117, 120 Thus as an alternative to fine mapping, haplotype analysis of a set of loci linked to Cmv1 was applied to a panel of 18 inbred strains characterized by their pattern of resistance or susceptibility to MCMV. 118, 119 A compilation of the results obtained for 27 independent markers evenly distributed over 1.8 Mb of genomic DNA demonstrated the presence of three major classes of independent haplotypes at this region (Figure 3) . A class presented in the CMV-resistant strain C57BL/6J and its close relative C57BL/10J showed the same haplotype. The second class, presented in six susceptible inbred strains including FVB/NJ, carried haplotypes related to that of Cmv1 r strains but presenting variations for loci distal to Ly49d. Genetic complementation of hybrids from an F 1 cross between FVB/NJ and the strain C.B6-Ly49e-D6Mit15 (congenic for a Cmv1 r segment) showed that FVB/NJ, and probably other strains with related haplotypes, carry a susceptibility allele named Cmv1 sFVB . 118 The third class presented in nine strains including BALB/cJ, A/J, DBA/2J known to carry the susceptibility allele Cmv1 s by genetic mapping (re-named Cmv1 sBALB ) carry a unique haplotype. 118 Remarkably, the haplotype of Cmv1 sBALB strains is distinct at all loci from those of either resistant, Cmv1 r , or susceptible, Cmv1 sFVB , mouse strains indicating an independent origin for Cmv1 sBALB and Cmv1 sFVB and raising the possibility of either genetic heterogeneity or allelic heterogeneity at Cmv1. Close inspection of the Cmv1 sFVB haplotypes indicated allele sharing from proximal markers, ruling out Ly49e, Ly49f and Ly49d as Cmv1 candidates. However, the region in disequilibrium with susceptibility extended over distally to Ly49d. These results together with the localization of Cmv1 as 117,120 with respect to genetic markers used for haplotype analysis. Results from two different reports 121, 122 were compiled to construct the individual haplotypes. Markers indicated by an asterisk are localized between D6Ott115 and 242D11L2, however, the precise order has not been determined. A color code is used to identify different alleles with pink indicating MCMV-resistant C57BL/6J alleles and yellow indicating MCMV-susceptible AKR/J alleles. 0 indicates that there is no PCR product. ND indicates not determined. All markers have been previously reported. 111, 112, 115, 118, 119 determined by the two previously described genetic maps 112, 115 made it difficult to rule out a possible contribution of several linked loci to the susceptibility/ resistance phenotype.
Studies using the recombinant inbred strain BXD-8 were instrumental to pinpoint the genetic defect associated with MCMV susceptibility. Recombinant inbred strains were derived by brother-sister mating starting at the F 2 generation originating from a cross between two standard inbred strains. As such, the BXD panel has been derived from progenitor strains C57BL/6 (Cmv1 r ) and DBA/2 (Cmv1 s ). BXD mice are homozygous for all loci, and their genome composition is on average 50% of C57BL/6 (B6) origin and 50% of DBA/2 origin. 121 Each line in the BXD panel will have a unique chromosomal composition that is a mosaic of chromosomal segments inherited from one or the other parental strain. The BXD-8 line was of particular interest since it was highly susceptible to MCMV infection but harbored a C57BL/6 haplotype at Cmv1 (Figure 2b) . 85 Linkage analysis using (BXD-8/Ty × C57BL/6)F2 populations together with genetic complementation experiments with congenic strains at Cmv1, indicated that the CMV susceptibility trait of BXD-8 was localized to the minimal Cmv1 interval. 77 Close inspection of this interval with 45 STSs and polymorphic markers, together with pulse-field gel electrophoresis identified a 23 kb deletion, 77 encompassing
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Ly49h (Figure 2b, c) . Moreover, analysis of the expression patterns of candidate NKC genes revealed that absence of the Ly49H activating receptor correlated with MCMV susceptibility, pointing to allelism between Ly49h and Cmv1. In addition, genotyping of mice with Ly49h derived markers together with RNA analysis (Vidal SM et al, personal communication) indicated the absence of this locus in all susceptible strains analysed ( Figure 3 ). This was further corroborated by treatment of MCMVresistant C57BL/6 mice with an anti-Ly49H antibody which resulted in the acquisition of a susceptible phenotype.
78,122
Overview of the Ly49 proteins
As stated previously, the Ly49 gene family contains at least 14 members, however, only a handful have been extensively studied to date (predominantly Ly49A, C, D and G2). Sequence alignments indicate that all Ly49 proteins are highly related and all are likely to be comprised of disulfide linked type II membrane spanning homodimers with an extracellular domain comprised of a C-type lectin motif. 123 Ly49 proteins are expressed predominantly on cells of the NK and NK T lineages although a small percentage of CD8 T cells also express Ly49 molecules. 124 This restricted expression pattern is consistent with the demonstrated importance of NK cells during CMV infection, particularly during the very earliest stages of infection. It has been established for some time now that Ly49A, C, D and G2 proteins all share a ligand specificity for classical MHC class I molecules 123 and this is consistent with the fact that all Ly49 proteins share a highly related extracellular domain. However, Ly49 proteins fall into two distinct categories based upon stimulatory or inhibitory signalling following ligand binding. These divergent functional activities are the consequence of the structural organization of their intracellular domains.
Inhibitory members of the Ly49 family contain an intracellular immunoreceptor tyrosine-based inhibitory motif (ITIM) (VXYXXV/L) which becomes tyrosine phosphorylated upon ligand binding leading to recruitment of the SHP-1 phosphatase. 125, 126 The exact target of the SHP-1 phosphatase in NK signaling is not yet clear, however, it is likely that it interferes with the signaling activities of spatially proximal signaling molecules. As stated above, all known ligands of Ly49 proteins are MHC class I molecules however there are distinct binding specificities for each Ly49 molecule. For example the inhibitory molecule Ly49A binds to H2D b,d,k,p whereas Ly49C bind to H2K b,d and H2D b,d,k . 123 The Ly49G2 inhibitory receptor seems to be specific for H2D
d . 127 Different subsets of NK cells appear to express overlapping sets of Ly49 molecules such that all cells express at least two different inhibitory receptors. 123 The percentage of cells expressing a given Ly49 molecule varies between different strains of mice and appears to be regulated by the expression of the cognate MHC class I molecule in that strain. 128, 129 This process has been termed 'receptor calibration' and although the precise mechanism behind this regulated pattern of expression has been the subject of intense scrutiny we still know little about the process. Recently, the crystal structure of an inhibitory Ly49 molecule, Ly49A, complexed with its ligand H2D d was reported. 130 Interestingly, the Ly49A homodimer was found to simultaneously contact two MHC class I molecules, one at the ␣2 domain of the peptide-binding site and the other at a site overlapping the CD8 binding site. The authors suggest that Ly49A dimers may in fact bind to one MHC class I molecule on a putative target cell using the former site, and a second neighboring MHC class I molecule on the NK cell itself using the latter site. Indeed it has been shown that an MHC class I/peptide complex can be simultaneously bound by both a T cell receptor (TCR) and an inhibitory Ly49A molecule suggesting a potential role in the activation of TCR-expressing NK T cells. 131 The second category of Ly49 molecules, the activating Ly49 molecules, have intracellular domains which are structurally distinct from those of the inhibitory Ly49 molecules. In contrast to the inhibitory Ly49 molecules, activating Ly49 receptors lack tyrosine residues in their intracellular domain and are thus incapable of signaling themselves. Rather, activating Ly49 receptors signal through an adapter molecule called DNAX activation protein 12 (DAP12) which associates with Ly49 through a non-covalent interaction using a charged residue in the membrane-spanning domain. 132, 133 DAP12 is a transmembrane protein with a very short extracellular domain containing a cysteine residue required for homodimer formation. The intracellular domain of DAP12 contains an immunoreceptor tyrosine-based activation motif (ITAM) which becomes phosphorylated upon ligand binding and recruits the cytoplasmic protein tyrosine kinases SYK and ZAP70. These in turn activate downstream signaling pathways that result in mobilization of intracellular calcium stores and activation of the cell's cytotoxic activity. In addition to complexing with activating Ly49 molecules, DAP12 functions as an adapter molecule for a number of activating surface receptors including mouse and human CD94/NKG2C, activating human KIR proteins (see below), and the myeloid cell-specific factors MDL-1, TREM-1 and TREM-2. 134 Consequently, mice deficient for DAP12 have diminished Ly49-mediated killing of certain tumors as well as other immune defects. 134 Surprisingly, humans with DAP12 have neurological symptoms characterized by progressive presenile frontal lobe dementia 135 indicating that DAP12 plays an important role in human brain function. However, no obvious immune defects have been reported associated with DAP12 deficiency in humans.
Of the 14 Ly49 molecules encoded in the Ly49 locus of mouse chromosome 6, only Ly49D and Ly49H have been identified as activating receptors. Ly49D is known to recognize the MHC class I molecule H2D d123 although the physiological significance of this recognition is not yet clear. Ligation of Ly49D with cross-linking antibodies or by H2D
d -expressing target cells results in both increased cytotoxicity and IFN-␥ production however both can be downregulated by a concurrent signal from the inhibitory receptor Ly49G2 (also H2D d -specific). 133 This latter finding suggests that signals from inhibitory Ly49 receptors are dominant over signals derived from activating Ly49 receptors. Although the shared presence of both positive and negative signaling receptors for the same ligand on a single NK cell presents a confusing picture in terms of NK function, recent evidence suggests that inhibitory or activation Ly49 receptors have different affinity for MHC class I and that this may be influenced by the peptide bound to MHC class I. 136 In addition, transgenic transfer of Ly49d B6 into BALB/c NK cells was recently shown to confer cytotoxic activity against Chinese hamster ovary (CHO) cells, establishing that Ly49D is the Chok gene product, 137 indicating that alternate Ly49D ligands may flag tumor cells for destruction by Ly49D-expressing NK cells. Recently, gene chip analyses have indicated that NK cells activated through cross-linking of Ly49D surface receptors upregulate a number of soluble mediators of inflammation, in particular the chemokines MIP1␣ and MIP1␤, suggesting that they may play a key role in initiating inflammation and recruitment of cells of the adaptive immune response. 138 The identification of Ly49H as an important molecule during early MCMV infection provides tantalizing evidence that the activating molecules of the NK cell system may actually have a built in ability to discriminate between non-infected cells versus those infected by common or important pathogens. Approximately half of the NK cell population in adult C57BL/6 mice express the Ly49H molecule and mouse strains lacking Ly49H have a higher burden of MCMV in the spleen during the first days after infection. 87 The Ly49H + population is rapidly expanded after MCMV infection and evidence suggests that Ly49H
+ positive cells at the site of infection are actively producing IFN-␥. 122 Together these data suggest that Ly49H
+ positive NK cells are receiving a stimulatory signal from the infection and that the stimulatory signal is delivered via Ly49H.
Model for the role of Ly49H in MCMV resistance
The regulation of the cytotoxic activity of NK cells by stimulatory and inhibitory receptors has been principally studied using tumor models where loss of MHC class I expression results in NK-mediated lysis, a process that fits with the 'missing self hypothesis' that was earlier proposed by Karre et al. 139 Lysis of MHC class I-negative tumors is now known to be the result of a loss in the ability to ligate the inhibitory Ly49 receptors which are activated in the presence of MHC class I, thereby preventing NK-mediated lysis of normal cells (Figure 4a ). In addition to tumor surveillance, NK cells also patrol for cells that are infected by virus because many viruses, including CMV, attempt to evade the scrutiny of the adaptive immune system by downregulating MHC class I expression, making them invisible to MHC class Irestricted CD8 + cytotoxic cells. 141 However viral- MCMV, as other viruses, attempts to evade the scrutiny of the adaptive immune system by downregulating MHC class I molecules on the surface of the infected cell. This mechanism, however, results in loss of signal from the NK cell inhibitory receptor and the infected cell thus becomes susceptible to NK-mediated killing. MCMV has one-upped the ante in this battle by encoding m144, an MHC class I homologue, that both avoids recognition by the adaptive immune system and tricks NK cells into thinking that the cell has 'normal' expression of MHC. Indeed loss of m144 results in reduced virulence, 140 probably as a result of NKmediated killing. (c) We now know that MCMV-resistance in Cmv1 r strains is mediated by the presence of the Ly49H stimulatory receptor on NK cells. Ly49H forms a complex with the signaling molecule DAP12 and thus ligand binding would be expected to result in NK stimulation via the immunoreceptor tyrosine-based activating domain (ITAM) of DAP12. The ligand of Ly49H is currently unknown, but mice that lack Ly49H on their NK cells are highly susceptible MCMV infection. Thus the ligand of Ly49H must be an endogenous or virally encoded molecule that is upregulated on MCMV-infected cells, rendering them susceptible to NK-mediated killing. As discussed in the text, it is possible that the MCMV-encoded MHC class I homologue m144 itself is the Ly49H-specific ligand.
Genes and Immunity mediated down-regulation of MHC class I expression would be expected to interrupt the signaling via inhibitory receptors on NK cells, rendering infected cells susceptible to NK lysis.
The apparent success of CMV to remain as a persistent latent infection for years despite the downregulation of MHC class I expression implies that it has acquired means of subverting the attack of both NK cells and T cells. 142 Recent evidence indicated that MCMV deploys an MHC class I homologue that serves to evade the host immune response. 140 Expression of this virally-encoded MHC class I homologue (m144) would serve the virus in two ways; first by interrupting the surveillance and destruction of the infected cell by virus-specific CD8 cytotoxic lymphocytes and second by engaging the MHC the class I specific inhibitory receptors of NK cells to avoid NK killing (Figure 4b) Figure 4c) . Regardless of the mechanism, the identification of a ligand for Ly49H should be considered a high priority for it would likely provide critical information regarding the functional role of NK cells during MCMV infection. Considering that all other members of the Ly49 family with known ligand specificity recognize classical MHC class I molecules, these should be the first potential ligands to be ruled in or ruled out as Ly49H-specific ligands.
Relevance to HCMV infection
NK cells are also thought to play a critical role in HCMV infections. 59 Although they lack Ly49 molecules, human NK cells have the KIR system which is able to detect the downregulation of MHC class I molecules on pathogeninfected cells. Inhibitory KIR have intracellular ITIM motifs and activating KIR associate with ITAM-containing DAP12 adapter molecules. However the extracellular domains of the KIR proteins are structurally distinct from those of Ly49, being comprised of immunoglobulin (Ig) domains rather than C-type lectin domains. Like Ly49 proteins, the KIR proteins recognize classical MHC class I molecules. 94 Thus downregulation of MHC class I molecules by HCMV would leave cells susceptible to lysis by NK cells in the absence of a KIR inhibitory ligand. As was observed with the m144 protein of MCMV, HCMV also encodes a MHC class I homologue called UL18.
143
UL18 associates with microglobulin and although it was hypothesized to represent a ligand for inhibitory receptors on NK cells, 144 subsequent analyses showed that it actually augmented NK-mediated lysis. 145 UL18 is now known to bind to an inhibitory receptor called leukocyte Ig-like receptor (LIR), however LIR appears to be expressed predominantly on monocytes and macrophages rather than NK cells thus its role in NK surveillance is not yet clear. 146 Analogous to the emerging role of the activating receptor Ly49H in MCMV infection, activating receptors of human NK cells seem to play a critical role in recognition of HCMV infected cells. The activating receptor NKG2D in particular seems to be important for control of viral replication as well as for control for tumorigenic precursors. 147 Like Ly49, NKG2D is a type II disulfide-linked dimer with a lectin-like extracellular domain. However unlike the activating Ly49 molecules NKG2D signals through the adaptor molecule DAP10 rather than DAP12. DAP10 does not contain a conventional ITAM motif but instead activates the phosphatidylinositol 3-kinase (PI3K) pathway.
148 NKG2D is expressed in both human and murine NK cells as well as most CD8
+ T cells and ␥␦ T cells. 149 The ligands for human NKG2D include the highly polymorphic MHC class I-related molecules MIC A and MIC B which seem to be upregulated on tumor cells or otherwise stressed cells. 150 NKG2D also binds to the ULBP family of MHC class I-related molecules 151 and the ULBP and MIC proteins provide a positive signal to NK cells that can overcome even the inhibitory signals provided by KIR molecules. Interestingly, another HCMV encoded protein, UL16, seems to block the binding of MIC B and ULBP 1 and 2 to NKG2D on human NK cells 151 thus providing another potential escape mechanism for the virus. Although homologues of MIC or ULBP have not been identified in the mouse, two novel ligands of murine NKG2D (H-60 and Rae1␤) have recently been identified. 152, 153 H-60 and Rae1␤ are distantly related to MHC class I molecules and, like the human MIC proteins, are found to be upregulated on a number of murine tumors. Given the apparent propensity of CMV to counteract any strategy used by the host to thwart infection it seems likely that MCMV-encoded inhibitors of H-60 and Rae1␤ are also likely to be found in the near future.
Concluding remarks
In conclusion, the identification of the activating Ly49H receptor as an important molecule for the activation of NK cells during the early stages of MCMV infection in the mouse constitutes an important step forward in understanding the function of these enigmatic cells. This finding provides additional evidence that NK cells have a capacity to discriminate between infected and uninfected cells despite the lack of variant receptors seen on cells of the adaptive immune system. The consequence of this recognition is removal of the suspect cell via NKmediated lysis thus the activities of the NK cell population must be kept closely harnessed. This fact helps to explain the presence of both activating and inhibitory receptors on NK cells, however one intriguing aspect regarding the repertoire of NK cell surface molecules is the apparent rapidity of their evolution. Indeed, although they are functionally analogous, the Ly49 gene family of mice and the KIR gene family of humans appear to have evolved independently as evidenced by their highly divergent ligand-binding domains. This divergence may be related to differences in MHC molecules which are common ligands of Ly49 and KIR proteins and which are themselves highly polymorphic. However, the MHC molecules of mouse and human are highly similar from a structural standpoint thus it is surprising that NK cells have evolved MHC class I-binding proteins that utilize completely distinct binding motifs. Furthermore the presence of at least 14 Ly49 family members in the mouse genome suggests that this locus has rapidly expanded since the divergence of mouse and humans. Thus although Ly49H appears to play an important role in MCMV infection, it is likely that other members of the Ly49 gene complex play distinct roles during infection by other viruses or other infectious diseases. For example, the importance of the Cmv1/Ly49H during MCMV infection, together with the role of Chok/Ly49D in tumor killing expands the functional diversity of Ly49 genes in NK 259 cells. These results suggest that Ly49 paralogous genes are also likely candidates for phenotypically defined loci in the NKC such as Rmp1, Scl and Idd6. The proposal that such functions would be strictly dependent on activating members of the Ly49 family supports a direct role of these molecules in recognition of infection. Similarly, it is possible that variation in KIR family members may contribute to susceptibility to HCMV and other related NK cell-mediated pathologies in humans.
